Literature DB >> 16831901

Regulating bone growth and development with bone morphogenetic proteins.

Phoebe S Leboy1.   

Abstract

There are many gene products reported to promote osteoblast differentiation and thus increase bone formation, but only the transcription factor Runx2 and members of the bone morphogenetic protein (BMP) family of growth/differentiation factors have been shown to be absolute requirements for osteogenesis. Mice lacking the transcription factor Runx2 (also known as cbfa1) develop no bone. Similarly, osteoblast differentiation and bone formation is blocked when BMP signaling is suppressed by overexpression of noggin, a selective BMP antagonist. It is therefore not unexpected that several different mechanisms have evolved to regulate the effects of BMP-induced signaling. In this session we focus on the multiple ways in which cells can modulate BMP-induced osteogenesis and mechanisms by which BMP signaling can lead to transcriptional control of gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831901     DOI: 10.1196/annals.1346.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

1.  alpha7 integrin expressing human fetal myogenic progenitors have stem cell-like properties and are capable of osteogenic differentiation.

Authors:  Nobuaki Ozeki; Moon Lim; Chung-Chen Yao; Mirek Tolar; Randall H Kramer
Journal:  Exp Cell Res       Date:  2006-09-23       Impact factor: 3.905

2.  BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties.

Authors:  Michael Rendl; Lisa Polak; Elaine Fuchs
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

3.  Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.

Authors:  Julian M W Quinn; Shanna Tam; Natalie A Sims; Hasnawati Saleh; Narelle E McGregor; Ingrid J Poulton; John W Scott; Matthew T Gillespie; Bruce E Kemp; B J W van Denderen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

4.  Potential Role of Local Estrogen in Enhancement of Fracture Healing: Preclinical Study in Rabbits.

Authors:  Mohammad Tahami; Behrooz Haddad; Armin Abtahian; Ali Hashemi; Amir Aminian; Sujith Konan
Journal:  Arch Bone Jt Surg       Date:  2016-10

5.  Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study.

Authors:  Marc Fajardo; Chuan-Ju Liu; Kenneth Egol
Journal:  Clin Orthop Relat Res       Date:  2009-07-14       Impact factor: 4.176

6.  Altered lumbar spine structure, biochemistry, and biomechanical properties in a canine model of mucopolysaccharidosis type VII.

Authors:  Lachlan J Smith; John T Martin; Spencer E Szczesny; Katherine P Ponder; Mark E Haskins; Dawn M Elliott
Journal:  J Orthop Res       Date:  2010-05       Impact factor: 3.494

7.  RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro.

Authors:  Kazushi Takayama; Akinobu Suzuki; Tomoya Manaka; Susumu Taguchi; Yusuke Hashimoto; Yuuki Imai; Shigeyuki Wakitani; Kunio Takaoka
Journal:  J Bone Miner Metab       Date:  2009-02-28       Impact factor: 2.626

Review 8.  MicroRNA biogenesis and regulation of bone remodeling.

Authors:  Kristina Kapinas; Anne M Delany
Journal:  Arthritis Res Ther       Date:  2011-05-27       Impact factor: 5.156

9.  The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.

Authors:  Gandhi N Solayar; Pauline M Walsh; Kevin J Mulhall
Journal:  BMC Musculoskelet Disord       Date:  2011-10-28       Impact factor: 2.362

10.  BMP13 prevents the effects of annular injury in an ovine model.

Authors:  Aiqun Wei; Lisa A Williams; Divya Bhargav; Bojiang Shen; Thomas Kishen; Neil Duffy; Ashish D Diwan
Journal:  Int J Biol Sci       Date:  2009-06-03       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.